参考文献/References:
［1］ 杨夏,李焕平.白芍总苷治疗系统性红斑狼疮患者的临床疗效及对免疫功能的影响［J］.世界中医药,2019,14(5):1270-1273.
［2］ SLEEMAN A,CLEMENTS J N.Abaloparatide:a new pharmacological option for osteoporosis［J］.Am J Health Syst Pharm， 2019，76(3):130-135.
［3］ CARLI L,TANI C,SPERA V,et al.Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus［J］.Lupus Sci Med，2016,3(1):98-114.
［4］ REES F,DOHERTY M,GREINGE M,et al.The burden of comorbidity in systemic lupus erythematosus in the United Kingdom 1999-2012［J］.Arthritis Care Res(Hoboken),2016,68(6):819-827.
［5］ RUARO B,CASABELLA A,PAOLINNO S,et al.Trabecular bone score and bone quality in systemic lupus erythematosus patients［J］.Front Med (Lausanne),2020,30(7):574-842.
［6］ GUO Q,FAN P,LUO J,et al.Assessment of bone mineral density and bone metabolism in young male adults recently diagnosed with systemic lupus erythematosus in China［J］.Lupus,2017,26(3):289-293.
［7］ SAO J R,DAS R S,DESAI M,et al.Association of high-density lipoprotein,triglycerides,and homocysteine with bone mineral density in young Indian tribal women［J］.Arch Osteoporos,2018,13(1):525-531.
［8］ BONNET N,BOURGOIN L,BIVER E,et al.RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass［J］.Clin Invest,2019,129(8):3214-3223.
［9］ PARIKH S V,ALMAANI S,BRODSKY S,et al.Update on lupus nephritis:core curriculum［J］.Am J Kidney Dis,2020,76(2):265-281.
［10］ RESENDE A L,REIS L M,DIAS C B,et al.Bone disease in newly diagnosed lupus nephritis patients［J］.PLoS One,2014,9(9):10-16.
［11］ SUN J,ZHANG S,LIU J S,et al.Expression of vitamin D receptor in renal tissue of lupus nephritis and its association with renal injury activity［J］.Lupus,2019，28(3):290-294.
［12］ EASTELL R,SZULC P.Use of bone turnover markers in post-menopausal osteoporosis［J］.Lancet Diabetes Endocrinol,2017,5(11):908-923.
［13］ LEPAIN J C,NAKAMURA M C,SHEPHERD J,et al.Assessment of bone remodelling in childhood-onset systemic lupus erythematosus［J］.Rheumatology (Oxford),2011,50(3):611-619.
［14］ HUSSEINI E A,CHAKRABORTY A,YUAN Q,et al.Urinary calcium excretion and bone turnover in osteoporotic patients［J］.Clin Nephrol,2017,88(11):239-247.
［15］ TIMLIN H,MANNO R,DOUGIA H.Hyperhomocysteinemia and lupus nephritis［J］.Cureus,2019,11(7):50-65.
［16］ 仲米倩.Hcy同型半胱氨酸与系统性红斑狼疮继发性骨质疏松的相关性研究［J］.中国医师进修杂志,2021,44(2):123-127.
［17］ MASSARO L,CECCARELLI F,COLASANTI T,et al.Anti-carbamylated protein antibodies in systemic lupus erythematosus patients with articular involvement［J］.Lupus,2018,27(1):105-111.
［18］ MOK C C,MAK A,MA K M.Bone mineral density in postmenopausal Chinese patients with systemic lupus erythematosus［J］.Lupus，2005，14(2):106-612.
［19］ 侯秀竹，张萌，崔丽艳.系统性红斑狼疮患者并发骨质疏松的血清免疫学相关危险因素分析［J］.山东医药,2016,55(24):79-80.
［20］ OWENS D J,ALLISON R,CLOSE G L .Vitamin D and the athlete:current perspectives and new challenges［J］.Sports Medicine,2018,48(1):3-16.
［21］ YAO H H,TANG S M,WANG Z M,et al .Study of bone mineral density and serum bone turnover markers in newly diagnosed systemic lupus erythematosus patients［J］.Beijing Da Xue Xue Bao,2018,50(6):998-1003.
［22］ KIM C S,HAN K D,JUNG J H,et al.Incidence and risk factors for osteoporotic fractures in patients with systemic lupus erythematosus versus matched controls［J］.Korean J Intern Med,2021,36(1):154-163.
［23］ ABDEL GALIL S M,EL-SHAFEY A M,ABDUL-MAKSOUD R S,et al.Interferon alpha gene expression and serum level association with low vitamin D levels in egyptian female patients with systemic lupus erythematosus［J］.Lupus,2018,27(2):199-209.
［24］ DUTTA C,KAKATI S,BARMAN B,et al.Vitamin D status and itsrelationship with systemic lupus erythematosus as a determinant and outcome of disease activity［J］.Horm Mol Biol Clin Investig,2019,38(3):64-83.
［25］ PREZ-FERRO M,ROMERO-BUENO F I,SERRANO DEL CASTILLO C,et al.A subgroup of lupus patients with nephritis,innate T cell activation and low vitamin D is identified by the enhancement of circulating MHC class I-related chain A［J］.Clin Exp Immunol,2019,196(3):336-344.
［26］ TOLOZA S M,COLE D E,GLADMN D D,et al.Vitamin D insu-fficiency in a large female SLE cohort［J］.Lupus,2010,19(1):13-22.
［27］ RAEISI D,ZARE M E,NASIR A,et al.Sex hormones and prolactin levels and their association with anti cardiolipin antibody in patients with systemic lupus erythematosus［J］.Iran J Allergy Asthma Immunol,2018,17(4):336-345.
［28］ HARDING G,MAK Y T,EVANS B,et al.The effects of dexamethasone and dehydroepiandrosterone (DHEA) on cytokines and receptor expression in a human osteoblastic cell line:potential steroid-sparing role for DHEA［J］.Cytokine,2006,36(2):57-68.
［29］ MCGRATH J J,SAHA S,BUREN T,et al.A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations［J］.J Steroid Biochem Mol Biol,2010,121(1/2):471-477.
相似文献/References:
[1]赵洪增,赵锋.系统性红斑狼疮200例胸部X线表现[J].新乡医学院学报,1997,14(01):050.
[2]张永喜 高 倩 刘玉府 杨 坤 孔小娟 张静涵 李万里 田玉慧 桂立辉.碳酸钙和生物钙对大鼠废用性骨质疏松症的作用[J].新乡医学院学报,1999,16(04):306.
[3]曹承华 王辉 何群力 范锡印.催乳素对雄性小鼠自身免疫病SLE的影响[J].新乡医学院学报,1999,16(01):019.
[4]李亚伟,徐剀.两种补钙方式预防孕妇骨质疏松疗效比较[J].新乡医学院学报,2003,20(02):135.
[5]李亚伟,徐 剀.两种补钙方式预防孕妇骨质疏松疗效比较[J].新乡医学院学报,2003,20(02):135.
[6]付克广,肖江喜,韩东明。.脊柱外伤及原发性骨质疏松椎体压缩的MRI诊断[J].新乡医学院学报,2003,20(03):172.
[7]田玉慧,娄静,李万里,等.麦胚提取物对去卵巢大鼠骨密度和矿物质的作用[J].新乡医学院学报,2003,20(03):153.
[8]付克广,肖江喜,韩东明.脊柱外伤及原发性骨质疏松椎体压缩的MRI诊断[J].新乡医学院学报,2003,20(03):172.
[9]田玉慧,娄 静,李万里,等.麦胚提取物对去卵巢大鼠骨密度和矿物质的作用[J].新乡医学院学报,2003,20(03):153.
[10]于德志,王武军,王振康,等.系统性红斑狼疮瓣膜性心脏病外科治疗的系统分析[J].新乡医学院学报,2006,23(03):000.